AMH rs12214196: Understanding Ovarian Reserve Markers
The rs12214196 variant is a polymorphism located within the AMH gene, which encodes the anti-Müllerian hormone. This genetic marker has been studied for its potential associations with variations in ovarian reserve markers and the rate at which ovarian follicles are recruited.
What each genotype means
Typical AMH genotype
This genotype represents the most common configuration at this location in the AMH gene. Research into this specific variant has not established a clear or consistent clinical impact on ovarian reserve or fertility outcomes, and current evidence remains limited regarding its functional significance.
Carried by approximately 64% of individuals in European populations, assuming a minor allele frequency of 0.20.
Heterozygous AMH variant
You carry one copy of the variant allele at this position. While some polymorphisms in the AMH gene have been investigated for potential links to ovarian reserve markers, studies have generally not found significant associations between this specific variant and clinical outcomes like ovarian response or fertility. This result should not be used to predict reproductive health or clinical outcomes.
Carried by approximately 32% of individuals in European populations, assuming a minor allele frequency of 0.20.
Homozygous AMH variant
You carry two copies of the variant allele at this position. Current scientific literature does not support a strong or definitive association between this genotype and meaningful differences in ovarian function or reproductive health. Because the evidence for this variant is limited, it is not considered a reliable marker for clinical decision-making.
Carried by approximately 4% of individuals in European populations, assuming a minor allele frequency of 0.20.
What is rs12214196?
The rs12214196 variant is a single nucleotide polymorphism (SNP) situated within the AMH gene locus. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a reproductive marker due to the critical role the AMH gene plays in female reproductive physiology. While many variants in the human genome are neutral, researchers investigate SNPs like rs12214196 to determine if they correlate with measurable differences in biological traits, such as hormone levels or reproductive milestones. Because this variant is located in a region associated with the regulation of ovarian function, it has become a subject of interest in studies examining the genetic architecture of the female reproductive system.
The Role of the AMH Gene
The AMH gene provides instructions for producing the anti-Müllerian hormone, a protein that is essential for sexual differentiation in the developing fetus. In adult females, AMH is produced by the granulosa cells of growing ovarian follicles. It serves as a key regulator of the ovarian reserve, which refers to the pool of remaining primordial follicles in the ovaries. By inhibiting the recruitment of these follicles, AMH helps manage the pace at which the ovarian reserve is depleted over a woman's reproductive lifespan. Because serum AMH levels are a standard clinical proxy for ovarian reserve, genetic variations that potentially influence AMH expression or function are closely scrutinized for their impact on reproductive health and the timing of menopause.
Research and Evidence Strength
Current evidence linking rs12214196 to specific clinical outcomes is considered limited. While the AMH gene is well-established as a central player in ovarian biology, the functional impact of this specific SNP remains a subject of ongoing investigation. Some studies have explored how polymorphisms in the AMH pathway relate to conditions like primary ovarian insufficiency or polycystic ovary syndrome, but results are often inconsistent across different ethnic populations. It is important to note that many genetic associations with reproductive traits are complex and polygenic, meaning they are influenced by many variants rather than a single SNP. Consequently, rs12214196 should be viewed as a marker of interest in research settings rather than a definitive diagnostic tool for predicting individual reproductive capacity.
Population Frequency
The frequency of genetic variants can vary significantly depending on ancestral background. For rs12214196, the minor allele frequency (MAF) is approximately 0.20 in European cohorts. This indicates that the variant is relatively common in these populations, appearing in a significant portion of the population. However, frequency data can differ substantially when looking at non-European groups, and researchers often emphasize the importance of diverse datasets to fully understand the distribution of such variants. Because this variant is common, it is likely that a large number of healthy individuals carry one or two copies of the minor allele, reinforcing the idea that its presence alone does not necessarily indicate a clinical condition.
Interpreting Your Genetic Information
If you have received information about your genotype for rs12214196, it is essential to understand that this data is for educational purposes. Genetic markers are statistical associations observed in large groups and cannot predict individual health outcomes with certainty. Many factors, including age, lifestyle, and other genetic variants, contribute to reproductive health. You cannot use this information to diagnose yourself or to make medical decisions regarding fertility or hormone treatments. If you have concerns about your reproductive health, ovarian reserve, or hormone levels, the most appropriate step is to consult with a reproductive endocrinologist or a qualified healthcare provider. They can interpret your clinical test results in the context of your personal medical history and provide guidance based on established medical standards.
How common is this variant?
The rs12214196 variant has a minor allele frequency of approximately 0.20 in European cohorts, making it a relatively common polymorphism.
Frequently asked questions
Does having the rs12214196 variant mean I have fertility issues?
No. This variant is a statistical marker studied in research populations and is not a diagnostic test for fertility. Many factors influence reproductive health, and the presence of this variant does not determine your individual fertility status.
Can I use this SNP to predict when I will reach menopause?
Current research does not support using rs12214196 to predict the timing of menopause. While some genetic variants are associated with the age of menopause, this specific SNP is primarily studied in the context of AMH levels and follicular recruitment.
Should I get my AMH levels tested if I have this variant?
Decisions about clinical testing should be made with a healthcare provider. If you have concerns about your reproductive health, a doctor can determine if an AMH blood test is appropriate for your specific clinical situation.
Is this variant linked to PCOS?
Some studies have investigated the role of AMH gene variants in polycystic ovary syndrome (PCOS), but results are mixed. There is no definitive evidence that rs12214196 is a primary cause of PCOS.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12214196?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in AMH
Loss-of-function AMH mutation precluding regression of female internal reproductive structures in 46,XY males.
Missense mutation in anti-Müllerian hormone resulting in impaired AMH signaling and persistent Müllerian duct syndrome type 1.
Non-synonymous variant (p.Ile49Ser) in anti-Müllerian hormone modifying receptor interaction and associated with circulating AMH bioactivity and follicular recruitment.